ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

Treatment with a mineralocorticoid receptor blocker esaxerenone on top of the first-line therapy: promise in uncontrolled hypertension.

Masashi MukoyamaPubMed ↗Publisher ↗

No numbers read from the abstract.